Metformin induces senescence of colorectal cancer cells through PP2A/AKT pathway

Jianying YANG; Lingqiao WANG; Weiyan CHEN; Yao TAN; Huidong JIN; Yi ZENG; Chengwei GUO; Yan SUN; Wenyu WANG; Ziyuan ZHOU; Guanghong YANG

doi:10.16016/j.1000-5404.202103252

您当前的位置：

首页 >

文章列表页 >

Metformin induces senescence of colorectal cancer cells through PP2A/AKT pathway

Basic Medicine | 更新时间：2026-01-09

- Metformin induces senescence of colorectal cancer cells through PP2A/AKT pathway
- Journal of Third Military Medical University Vol. 43, Issue 19, Pages: 1860-1869(2021)
- 作者机构：
  
  1.550025 贵阳，贵州医科大学公共卫生学院
  2.400038 重庆，陆军军医大学(第三军医大学)军事预防医学系环境卫生学教研室
- 作者简介：
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(81273156)
- DOI：10.16016/j.1000-5404.202103252
  CLC： R735.35;R966;R977.15
- Received：30 March 2021，
  
  Revised：2021-04-13，
  
  Published：15 October 2021
- 稿件说明：
移动端阅览
Jianying YANG, Lingqiao WANG, Weiyan CHEN, et al. Metformin induces senescence of colorectal cancer cells through PP2A/AKT pathway[J]. Journal of Third Military Medical University, 2021, 43(19): 1860-1869.
DOI：

Jianying YANG, Lingqiao WANG, Weiyan CHEN, et al. Metformin induces senescence of colorectal cancer cells through PP2A/AKT pathway[J]. Journal of Third Military Medical University, 2021, 43(19): 1860-1869. DOI： 10.16016/j.1000-5404.202103252.

摘要

目的

明确二甲双胍(1，1-二甲基双胍盐酸盐，Met)是否通过诱导细胞衰老抑制结直肠癌细胞增殖，并初步探讨其诱导细胞衰老的机制。

方法

以不同浓度Met(0、2.5、5.0、10.0、20.0、40.0 mmol/L)处理结直肠癌LOVO、SW480细胞，采用CCK-8检测细胞活力，流式细胞仪检测细胞凋亡和周期。根据凋亡结果将实验分为对照组、5.0 mmol/L Met组(

=3)，采用EdU和克隆形成实验检测细胞增殖，衰老相关β-半乳糖苷酶(SA-β-gal)染色检测细胞衰老代谢，ELASA检测蛋白磷酸酶2A(protein phosphatase 2A

PP2A)酶活性，Western blot检测蛋白表达。用PP2A抑制剂LB-100联合Met处理细胞并分为对照组、Met组、Met+LB-100组、LB-100组(

=3)，再次用CCK-8和克隆形成实验检测细胞增殖，SA-β-ga1染色检测细胞衰老情况。

结果

Met以浓度和时间依赖方式显著抑制结直肠癌细胞LOVO、SW480增殖(

0.05)；低浓度(≤5.0 mmol/L)Met作用下，细胞无明显凋亡，但有明显增殖抑制和G

期阻滞；细胞呈大而扁平、空泡化增多的典型衰老样态，衰老标志SA-β-gal阳性细胞明显增加；此时，PP2A蛋白表达无改变，但磷酸化水平显著降低，PP2A酶活性则显著升高(

0.05)，其下游AKT蛋白磷酸化水平降低，衰老相关蛋白P53、P21等表达明显增加。PP2A抑制剂LB-100联合Met处理后，可明显逆转Met对细胞增殖的抑制，并延缓Met诱导的细胞衰老。

结论

低浓度Met可通过PP2A/AKT通路诱导细胞衰老从而抑制结直肠癌细胞增殖。

Abstract

Objective

To determine whether metformin(Met) inhibits the proliferation of colorectal cancer cells by inducing cell senescence

and to preliminarily explore the underlying mechanism.

Methods

LOVO and SW480 colorectal cancer cells were treated with different concentrations of Met(0

2.5

5.0

10.0

20.0 and 40.0 mmol/L). The cell viability was detected by CCK-8 assay

and apoptosis and cell cycle were detected by flow cytometry. According to the results of apoptosis

differences between control group (0 mmol/L) and 5.0 mmol/L Met group(

=3) were compared in following experiments. Cell proliferation was detected by CCK-8 assay

EdU assay

and clone formation assay

senescence metabolism was detected by senescence-associated β-galactosidase(SA-β-gal)

staining

protein phosphatase 2A(PP2A) enzyme activity was measured with ELASA

and protein expression was detected with Western blotting. PP2A inhibitor LB-100 was used to treat the cells alone or combined with Met

and then the cells were divided into control group

Met group

Met+LB-100 group

and LB-100 group(

=3). Above experiments were performed again.

Results

Met treatment significantly inhibited LOVO and SW480 cells proliferation in a concentration- and time-dependent manner(

0.05). Under the treatment of low concentration(≤5.0 mmol/L) of Met

the cells presented no obvious apoptosis

but were obviously inhibited for proliferation and arrested at G

phase. The cells displayed a typical senescence-like morphology of large

flat and vacuolated

and the number of SA-β-gal positive cells was increased significantly. For PP2A

total protein expression showed no change

but phosphorylation level decreased obviously and PP2A activity increased statistically(

0.05)

in the meantime

the phosphorylation level of downstream AKT protein decreased and senescence-related proteins p53 and P21 increased significantly. Treatment by PP2A inhibitor LB-100 combined with Met significantly reversed the inhibition of Met on cell proliferation and delayed Met-induced cell senescence.

Conclusion

Low concentration of Met can induce cell senescence through PP2A/AKT pathway and then inhibit the proliferation of colorectal cancer cells.

关键词

Keywords

references

BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI:10.3322/caac.21492.

WU C, LI M, MENG H, et al . Analysis of status and countermeasures of cancer incidence and mortality in China[J ] . Sci China Life Sci, 2019, 62(5): 640-647. DOI:10.1007/s11427-018-9461-5.

WYLD L, BELLANTUONO I, TCHKONIA T, et al . Senescence and cancer: A review of clinical implications of senescence and senotherapies[J ] . Cancers(Basel), 2020, 12(8). DOI:10. 3390/cancers12082134.16/j.canlet. 2017. 09. 027.

ZHOU D, BORSA M, SIMON A K. Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells[J]. Aging Cell, 2021, 20(2): e13316. DOI:10.1111/acel.13316.

OU H L, SCHUMACHER B. DNA damage responses and p53 in the aging process[J]. Blood, 2018, 131(5): 488-495. DOI:10.1182/blood-2017-07-746396.

EWALD J A, DESOTELLE J A,WILDING G, et al . Therapy-induced senescence in cancer[J ] . J Natl Cancer Inst, 2010, 102(20): 1536-1546. DOI:10.1093/jnci/djq364.

XUE W, ZENDER L, MIETHING C, et al . Senescence and tumour clearance is triggere d by p53 restoration in murine liver carcinomas[J ] . Nature, 2007, 445(7128): 656-660. DOI:10.1038/nature05529.

CAIRNEY C J, BILSLAND A E, EVANS T R, et al . Cancer cell senescence: a new frontier in drug development[J ] . Drug Discov Today, 2012, 17(5/6): 269-276. DOI:10.1016/j.drudis.2012.01.019.

MALLIK R, CHOWDHURY T A. Metformin in cancer[J]. Diabetes Res Clin Pract, 2018, 143: 409-419. DOI:10.1016/j.diabres.2018.05.023.

SAFE S, NAIR V, KARKI K. Metformin-induced anticancer activities: recent insights[J]. Biol Chem, 2018, 399(4): 321-335. DOI:10.1515/hsz-2017-0271.

KAMARUDIN M N A, SARKER M M R, ZHOU J R, et al . Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects[J ] . J Exp Clin Cancer Res, 2019, 38(1): 491. DOI:10.1186/s13046-019-1495-2.

XIA C, YANG F, HE Z, et al . iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin[J ] . Biomed Pharmacother, 2020, 123: 109762. DOI:10.1016/j.biopha.2019.109762.

LI P, ZHAO M, PARRIS A B, et al . p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells[J ] . Biochem Biophys Res Commun, 2015, 464(4): 1267-1274. DOI:10.1016/j.bbrc.2015.07.117.

WILLIAMS C C, SINGLETON B A, LLOPIS S D, et al . Metformin induces a senescence-associated gene signature in breast cancer cells[J ] . J Health Care Poor Underserved, 2013, 24(1 suppl): 93-103. DOI:10.1353/hpu.2013.0044.

YI G, HE Z, ZHOU X, et al . Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway[J ] . Int J Oncol, 2013, 43(5): 1503-1510. DOI:10.3892/ijo.2013.2077..

ZHOU X, CHEN J, CHEN L, et al . Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts[J ] . Cancer Lett, 2017, 411: 1-11. DOI:10.1016/j.canlet.2017.09.027.

ABU E, STRASSBURGER W, QAISER T, et al . Differences in p53 status significantly influence the cellular response and cell survival to 1, 25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cell s[J ] . Mol Carcinog, 2017, 56(11): 2486-2498. DOI: 10. 1002/mc. 22696.

HOSONO K, ENDO H, TAKAHASHI H, et al . Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase[J ] . Mol Carcinog, 2010, 49(7): 662-671. DOI: 10.1002/mc.20637.

MOGAVERO A, MAIORANA M V, ZANUTTO S, et al . Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production[J ] . Sci Rep, 2017, 7(1): 15992. DOI:10.1038/s41598-017-16149-z.

FOWLE H, ZHAO Z, GRAÑA X. PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer[J]. Adv Cancer Res, 2019, 144: 55-93. DOI:10.1016/bs.acr.2019.03.009.

吴燕芳. PP2A复合物在Ras引起的细胞衰老中的功能初探[D]. 江苏大学, 2017.

WU Y F. The preliminary study on the function of PP2A complex in cellular senescence induced by Ras[D]. Jiangsu University, 2017.

MANNAVA S, OMILIAN A R, WAWRZYNIAK J A, et al . PP2A-B56α controls oncogene-induced senescence in normal and tumor human mela nocytic cells[J ] . Oncogene, 2012, 31(12): 1484-1492. DOI:10.1038/onc.2011.339.

O'CONNOR C M, PERL A, LEONARD D, et al . Therapeutic targeting of PP2A[J ] . Int J Biochem Cell Biol, 2018, 96: 182-193. DOI:10.1016/j.biocel.2017.10.008.

CRISTÓBAL I, GARCIA-ORTI L, CIRAUQUI C, et al . PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect[J ] . Leukemia, 2011, 25(4): 606-614. DOI:10.1038/leu.2010.294.

XIONG Y, JING X P, ZHOU X W, et al . Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A(tyrosine 307) phosphorylation[J ] . Neurobiol Aging, 2013, 34(3): 745-756. DOI:10.1016/j.neurobiolaging.2012.07.003.

CRISTÓBAL I, RINCÓN R, MANSO R, et al . Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation[J ] . Biochim Biophys Acta, 2014, 1842(9): 1823-1829. DOI:10.1016/j.bbadis.2014.06.032.

KAWASHIMA I, KIRITO K. Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56alpha subunit[J]. Exp Hematol, 2016, 44(12): 1156-1165. DOI:10.1016/j.exphem.2016.08.005.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

GPX7 regulates proliferation and senescence of hepatocellular carcinoma cells through the PI3K-AKT pathway

Effects of exosomes derived from placental mesenchymal stem cells on high glucose-induced senescence in human dermal fibroblasts

Effect of diosmetin on proliferation, apoptosis and migration of colorectal cancer cells by regulating STX17-AS1/miR-383-5p axis

Prognostic significance of P5CS in colorectal cancer and its effects on myelocytomatosis oncogene expression

Inhibitory effects of miR-34a on NOTCH1 gene expression and SW480 cell proliferation

Related Author

WANG Ruiguan

WANG Jing

YAN Maohui

LI Xinji

SUN Zhijia

Xiaowei BIAN

Cuiping ZHANG

Bingmin LI

Related Institution

Faculty of Hepatobiliary and Pancreatic Surgery， First Medical Center， General Hospital of PLA， Beijing, Air Force Medical Center of PLA

Department of Hepatobiliary Surgery， Eighth Medical Center， General Hospital of PLA， Beijing, Air Force Medical Center of PLA

Department of Radiation Oncology, Air Force Medical Center of PLA

Graduate School, Tianjin Medical University

Research Center for Tissue Repair and Regeneration, Beijing Key Research Laboratory of Skin Injury, Repair and Regeneration, Division of innovative Medical Research, Chinese PLA General Hospital

⁰